Fig. 1From: Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection Details of Carbapenem Therapy.DOT days of therapy, OPAT outpatient parenteral antimicrobial therapy Back to article page